期刊文献+

泛素-蛋白酶体通路 被引量:4

Ubiquitin-proteasome pathway
暂未订购
导出
摘要 泛素 蛋白酶体通路介导的细胞蛋白降解是一个复杂、缜密的调控过程 ,同时在细胞周期、基因转录及表达、抗原提呈和炎症演进等方面发挥调控作用 ,尤其是通过降解细胞各通路的抑制因子或 /和激活因子发挥上调或下调作用 ;而且泛素 蛋白酶体通路的异常与诸多疾病如恶性肿瘤、神经变性疾病、遗传性疾病、炎症、心肌病的致病机制有关。对于细胞应用该通路降解靶蛋白机制的阐明 。
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期230-232,共3页 Journal of Central South University :Medical Science
  • 相关文献

参考文献17

  • 1Weekes J, Morrison K, Mullen A,et al. Hyperuibiquitination of proteins in dilated cardiomyopathy [J]. Proteomics, 2003,3(2):208-216.
  • 2Gillessen S, Groettup M, Cerny T. The proteasome, a new target for cancer therapy [J]. Onkologie, 2002, 25(6):534-539.
  • 3Elliott PJ, Zollner TM, Boehncke WH. Proteasome inhibition: a new anti-inflammatory strategy [J]. J Mol Med, 2003,81(4):235-245.
  • 4Bossola M, Muscaritoli M, Costelli P,et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients [J]. Ann Surg, 2003, 237(3):384-389.
  • 5Ben-Neriah Y. Regulatory function of ubiquitination in the immune system [J]. Nat Immunol, 2002, 3(1):20-26.
  • 6Koegl M, Hoppe T, Schlenker S,et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly [J]. Cell, 1999, 96: 635-634.
  • 7hrower JS, Hoffman L, Rechsteiner M,et al. Recognition of the polyubiquitin proteolytic signal [J]. EMBO J, 2000, 19:94-102.
  • 8Adams J. Proteasome inhibition in cancer: development of PS-341 [J]. Semin Oncol, 2001, 28(6):613-619.
  • 9Kornitzer D, Ciechanover A. Modes of regulation of ubquitin-mediated protein degradation [J]. J Cell Physiol, 2000, 182:1-11.
  • 10Kipreos ET, Pagano M. The F-box protein family [J]. Genome Biology, 2000, 1(5):1-7.

同被引文献52

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部